cotsiranib

cotsiranib
Trade Name
Orphan Indication Bile duct cancer
USA Market Approval USA
USA Designation Date 2017-11-29 00:00:00
Sponsor Sirnaomics, Inc.;401 Professional Drive, Suite 280;Gaithersburg, Maryland, 20879